Tag: Farapulse
Boston Scientific receives US FDA approval for expanded labelling of Farapulse...
Boston Scientific Corporation has received US Food and Drug Administration (FDA) approval to expand the instructions for use (IFU) labelling for the Farapulse pulsed...
Second phase of Boston’s ADVANTAGE AF study meets primary safety and...
Boston Scientific has announced positive 12-month primary endpoint results from the second phase of the ADVANTAGE AF clinical trial evaluating the use of the...
SINGLE SHOT CHAMPION data leave “no doubt” that PFA is non-inferior...
At this year’s European Heart Rhythm Association (EHRA) congress (30 March–1 April 2025, Vienna, Austria), a late-breaking presentation of data from the SINGLE SHOT...
Farapulse PFA system demonstrates superior efficacy to cryoablation catheter in paroxysmal...
New findings from the SINGLE SHOT CHAMPION trial, presented at the ongoing European Heart Rhythm Association (EHRA) congress (30 March–1 April 2025, Vienna, Austria)...
Boston Scientific obtains CE mark for next generation of cardiac mapping...
Boston Scientific Corporation has announced it has received CE-mark approval for its navigation-enabled Farawave Nav ablation catheter in the treatment of paroxysmal atrial fibrillation...
Cardiac Rhythm News’ top stories of 2024
From first-time clinical data to major industry debuts, here are Cardiac Rhythm News’ 10 most popular stories of 2024.
1. Abbott joins the pulsed field...
New data presented on Farapulse and Watchman FLX devices at AF...
Boston Scientific announced data supporting the use of the Farapulse pulsed field ablation (PFA) system and the Watchman FLX left atrial appendage closure (LAAC) device,...
Boston Scientific launches next generation of cardiac mapping for Farapulse PFA...
Boston Scientific Corporation has announced that it has received US Food and Drug Administration (FDA) approval of the navigation-enabled Farawave Nav ablation catheter for...
Boston Scientific receives Japanese regulatory approval for Farapulse PFA system
Boston Scientific has announced receipt of Pharmaceuticals and Medical Device Agency (PMDA) approval in Japan for the Farapulse pulsed field ablation (PFA) system. The...
Advertorial: PFA is now “beyond the phase of excitement”
This advertorial is sponsored by Boston Scientific
The arrival of pulsed-field ablation (PFA) has been heralded by many experts in the field of arrhythmia management...
HRS 2024: FARADISE registry “underscores” safety and efficacy of Farapulse PFA...
Insights from the FARADISE registry, studying real-world outcomes from more than 1,000 patients to have undergone catheter ablation for paroxysmal and non-paroxysmal atrial fibrillation...
Advertorial: Milestone procedure underscores optimism for future of pulsed field ablation
This advertorial is sponsored by Boston Scientific
Physicians at Na Homolce Hospital (Prague, Czech Republic) have recently completed their 2,000th clinical case using the FARAPULSE...